Cargando…
Rewiring Drug Research and Development through Human Data-Driven Discovery (HD(3))
In an era of unparalleled technical advancement, the pharmaceutical industry is struggling to transform data into increased research and development efficiency, and, as a corollary, new drugs for patients. Here, we briefly review some of the commonly discussed issues around this counterintuitive inn...
Autores principales: | Jackson, David B., Racz, Rebecca, Kim, Sarah, Brock, Stephan, Burkhart, Keith |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10303279/ https://www.ncbi.nlm.nih.gov/pubmed/37376121 http://dx.doi.org/10.3390/pharmaceutics15061673 |
Ejemplares similares
-
Predicting potential adverse events using safety data from marketed drugs
por: Daluwatte, Chathuri, et al.
Publicado: (2020) -
Computational cell fate modelling for discovery of rewiring in apoptotic network for enhanced cancer drug sensitivity
por: Mishra, Shital K, et al.
Publicado: (2015) -
Association Between Serotonin Syndrome and Second‐Generation Antipsychotics via Pharmacological Target‐Adverse Event Analysis
por: Racz, Rebecca, et al.
Publicado: (2018) -
Deep Learning-driven research for drug discovery: Tackling Malaria
por: Neves, Bruno J., et al.
Publicado: (2020) -
Accelerating scientific discoveries through data-driven innovations
por: Alexander, Francis J., et al.
Publicado: (2023)